Abstract
In this study, anti-inflammatory, wound healing and anti-ulcerogenic properties of chitosan were evaluated ‘in vivo’ using wistar rats and swiss adult mice and the anti-proliferative activity was tested ‘in vitro’. The tested chitosans displayed no anti-proliferative or anti-inflammatory properties. The cytotoxic activity of chitosan was found to be non-existent towards eight tumoral cell lines and no significant differences were found in the ear edema (anti-inflammatory model) induced by croton oil and chitosan groups. However, chitosan showed good anti-ulcerative and wound healing abilities. Low molecular weight (LMW) chitosan effectively reduced ulcerative wounds induced by ethanol, while high molecular weight (HMW) chitosan helped retain the stomachal folds rendering a gastro protective effect. These results suggest that chitosan can potentially be used in the treatment of peptic ulcers. HMW chitosan also potentiated the healing process both in normal and diabetic rats, probably without induction of fibroblast growth but via collagen synthesis.
Keywords: Chitosan, wound healing, anti-ulcerative, anti-proliferative, biological properties, in vivo testing.
Current Bioactive Compounds
Title:Anti-Proliferative, Anti-Inflammatory, Anti-Ulcerogenic and Wound Healing Properties of Chitosan
Volume: 12 Issue: 2
Author(s): Freni K. Tavaria, Michelle P. Jorge, Ana Lúcia T.G. Ruiz, Manuela E. Pintado and Joao E. Carvalho
Affiliation:
Keywords: Chitosan, wound healing, anti-ulcerative, anti-proliferative, biological properties, in vivo testing.
Abstract: In this study, anti-inflammatory, wound healing and anti-ulcerogenic properties of chitosan were evaluated ‘in vivo’ using wistar rats and swiss adult mice and the anti-proliferative activity was tested ‘in vitro’. The tested chitosans displayed no anti-proliferative or anti-inflammatory properties. The cytotoxic activity of chitosan was found to be non-existent towards eight tumoral cell lines and no significant differences were found in the ear edema (anti-inflammatory model) induced by croton oil and chitosan groups. However, chitosan showed good anti-ulcerative and wound healing abilities. Low molecular weight (LMW) chitosan effectively reduced ulcerative wounds induced by ethanol, while high molecular weight (HMW) chitosan helped retain the stomachal folds rendering a gastro protective effect. These results suggest that chitosan can potentially be used in the treatment of peptic ulcers. HMW chitosan also potentiated the healing process both in normal and diabetic rats, probably without induction of fibroblast growth but via collagen synthesis.
Export Options
About this article
Cite this article as:
K. Tavaria Freni, P. Jorge Michelle, Lúcia T.G. Ruiz Ana, E. Pintado Manuela and E. Carvalho Joao, Anti-Proliferative, Anti-Inflammatory, Anti-Ulcerogenic and Wound Healing Properties of Chitosan, Current Bioactive Compounds 2016; 12 (2) . https://dx.doi.org/10.2174/1573407212666160330204522
DOI https://dx.doi.org/10.2174/1573407212666160330204522 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Inducers of Heme Oxygenase-1
Current Pharmaceutical Design Influence of Tumor Microenvironment on the Distribution and Elimination of Nano-formulations
Current Drug Metabolism Gap Junctions as Targets for Cancer Chemoprevention and Chemotherapy
Current Drug Targets Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)
Current Drug Targets Prevalence of Oral and Systemic Manifestations in Pediatric HIV Cohorts with and without Drug Therapy
Current HIV Research Pathobiology and Prevention of Cancer Chemotherapy-Induced Bone Growth Arrest, Bone Loss, and Osteonecrosis
Current Molecular Medicine In Vivo Biological Evaluation of Ethyl 4-(7-hydroxy-4-methyl-2-oxoquinolin-1- ylamino)-coumarin-3-carboxylate as an Antitumor Agent
Anti-Cancer Agents in Medicinal Chemistry Effects of Agaricus Blazei Extract Plus Lactoferrin or Lactoferrin Alone on Tumor Growth and UFT-Induced Adverse Reactions in Sarcoma 180- or Highly Metastatic Osteosarcoma LM8-Bearing Mice
The Natural Products Journal Iron Chelators in Medicinal Applications - Chemical Equilibrium Considerations in Pharmaceutical Activity
Current Medicinal Chemistry Antiangiogenic Therapy
Current Pharmaceutical Design Therapeutic Strategies for Targeting BRAF in Human Cancer
Reviews on Recent Clinical Trials Antioxidant Properties of Melatonin and its Potential Action in Diseases
Current Topics in Medicinal Chemistry Non-viral Delivery Systems for the Application in p53 Cancer Gene Therapy
Current Medicinal Chemistry The Evolution of Diagnosis and Management of Pediatric Biliary Tract Rhabdomyosarcoma
Current Pediatric Reviews Tumor Bone Diseases: Molecular Mechanisms and Opportunities for Novel Treatments
Current Medicinal Chemistry - Anti-Cancer Agents The Interactions of Anticancer Agents with Tea Catechins: Current Evidence from Preclinical Studies
Anti-Cancer Agents in Medicinal Chemistry Development of Anti-Atherosclerosis Therapy Based on the Inflammatory and Proliferative Aspects of the Disease
Current Pharmaceutical Design Mesothelioma - Update on Management
Current Respiratory Medicine Reviews Anticancer Lignans - from Discovery to Biotechnology
Mini-Reviews in Medicinal Chemistry The Role of Neuronal Insulin/Insulin-Like Growth Factor-1 Signaling for the Pathogenesis of Alzheimer’s Disease: Possible Therapeutic Implications
CNS & Neurological Disorders - Drug Targets